Director received an award of 44 WST derivative securities | OQRO Insider trades- Derivative units · @ $370.76
Why it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Sep 30, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Oct 2, 2026
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000105770-26-000112
- Filed / recorded
Oct 2, 2026, 5:10 PM UTCAdded to OQROOct 2, 2026, 6:21 PM UTC Data qualityVerified: identifiers matched exactly IssuerWEST PHARMACEUTICAL SERVICES INC Reporting personJanet Brutschea Haugen SecurityPhantom Stock Unit TableDerivative (Table II) Transaction dateSep 30, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.
Around the same time
Derivative exercise or conversion — not an open-market buy.
24K → 22K shares held−10% of their stake
West Pharmaceutical Services's Sr. VP & Chief HR Officer sold $863K of West Pharmaceutical Services shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.